Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease

Neuronal stem cell (NSC) grafts have been investigated as a potential neuro-restorative therapy in Parkinson’s disease (PD) but their use is compromised by the death of grafted cells. We investigated the use of Cerebrolysin (CBL), a neurotrophic peptide mixture, as an adjunct to NSC therapy in the α...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockenstein, Edward, Desplats, Paula, Ubhi, Kiren, Mante, Michael, Florio, Jazmin, Adame, Anthony, Winter, Stefan, Brandstaetter, Hemma, Meier, Dieter, Moessler, Herbert, Masliah, Eliezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938121/
https://www.ncbi.nlm.nih.gov/pubmed/27429559
http://dx.doi.org/10.4137/JEN.S25521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938121/
https://www.ncbi.nlm.nih.gov/pubmed/27429559
http://dx.doi.org/10.4137/JEN.S25521

Ejemplares similares